Successful treatment of thrombocytopenia in primary antiphospholipid antibody syndrome with the anti-CD20 antibody rituximab—monitoring of antiphospholipid and anti-GP antibodies: a case report

被引：0
|
作者：
R. Trappe
A. Loew
P. Thuss-Patience
B. Dörken
H. Riess
机构：
[1] Charité Universitätsmedizin Berlin,Department of Hematology and Oncology
来源：
Annals of Hematology | 2006年 / 85卷
关键词：
Idiopathic Thrombocytopenic Purpura; Lupus Anticoagulant; High Platelet Count; Chronic Idiopathic Thrombocytopenic Purpura; Recurrent Fetal Loss;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：134 / 135
页数：1
相关论文
共 50 条
  • [31] Successful Treatment of Lupus Anticoagulant Hypoprothrombinemia Syndrome with Anti CD20 Antibody, Rituximab
    Tewari, Sayani
    Khan, Osman
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S12 - S13
  • [32] Anti-platelet antibodies in patients with systemic lupus erythematosus and the primary antiphospholipid antibody syndrome: Their relationship with the observed thrombocytopenia
    Macchi, L
    Rispal, P
    ClofentSanchez, G
    Pellegrin, JL
    Nurden, P
    Leng, B
    Nurden, AT
    BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (02) : 336 - 341
  • [33] Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: A case report
    Aranda, JM
    Scornik, JC
    Normann, SJ
    Lottenberg, R
    Schofield, RS
    Pauly, DF
    Miles, M
    Hill, JA
    Sleasman, JW
    Skoda-Smith, S
    TRANSPLANTATION, 2002, 73 (06) : 907 - 910
  • [34] Recurrent idiopathic membranous nephropathy in the renal allograft: successful treatment with the anti-CD20 monoclonal antibody rituximab
    Ladino, Marco
    Roth, David
    CLINICAL KIDNEY JOURNAL, 2009, 2 (05): : 395 - 397
  • [35] Successful treatment of cold agglutinin disease with anti-CD20 antibody (rituximab) in a patient with systemic lupus erythematosus
    Kotani, T.
    Takeuchi, T.
    Kawasaki, Y.
    Hirano, S.
    Tabushi, Y.
    Kagitani, M.
    Makino, S.
    Hanafusa, T.
    LUPUS, 2006, 15 (10) : 683 - 685
  • [36] Anti-CD20 monoclonal antibody (rituximab) as an adjunct in the treatment of giant cell arteritis
    Bhatia, A
    Ell, PJ
    Edwards, JCW
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (07) : 1099 - 1100
  • [37] Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance
    Mitchell R Smith
    Oncogene, 2003, 22 : 7359 - 7368
  • [38] The use of rituximab, anti-CD20 monoclonal antibody, in pediatric transplantation
    Pescovitz, MD
    PEDIATRIC TRANSPLANTATION, 2004, 8 (01) : 9 - 21
  • [39] Rituximab, an anti-CD20 monoclonal antibody: History and mechanism of action
    Pescovitz, MD
    AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (05) : 859 - 866
  • [40] The anti-CD20 monoclonal antibody rituximab to treat acquired haemophilia A
    D'Arena, Giovanni
    Grandone, Elvira
    Di Minno, Matteo N. D.
    Musto, Pellegrino
    Di Minno, Giovanni
    BLOOD TRANSFUSION, 2016, 14 (03) : 255 - 261
12345